Testing effectiveness (Phase 2)Study completedNCT03233217
What this trial is testing
Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Patients ≥65 Years
Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 175